Raised blood lead levels in children

RUTH RUGGLES.JPG

Lead investigator 

Dr. R Ruggles 

Email: slic@hpa.org.uk
Website: Surveillance of Lead in Children study           

Overview

  • Public health interventions have succeeded in removing most sources of lead from the environment.
  • A small proportion of children continue to be exposed to harmful levels of lead, usually in the home.
  • Exposure to lead in children is associated with a range of adverse health effects, from sub-clinical neurodevelopmental impairment to encephalitis.
  • There are no reliable data on the incidence or prevalence of clinically significant lead toxicity or the prevalence of elevated blood lead concentrations in children in the UK.
  • Currently, the UK has no formal monitoring of childhood blood lead concentrations within laboratory or clinical systems and the public health response to such cases is likely to be sub-optimal.
  • A recent case series indicates that significant obstacles are often encountered in the effective and timely management of cases.
  • The aim of this study is to provide an estimate of the incidence of elevated blood lead concentrations in children.
  • The study will provide important information on the management of cases, both clinically and in terms of the public health response.         

Case defintion: Any child, less than 16 years of agge, with a blood lad concentration reported by the laboratory of as more than or equal to 10µg/dL (or 0.48µmol/L), with ot without any of the accepted clinical signs and sumptoms of lead toxicity.

Reporting instructions: Please report any new cases you have seen in the last month which meet the surveillance definiton.

Duration: June 2010 – June 2012 inclusive (with follow-up until July 2013)  

Funding: Health Protection Agency        

Ethical approval: This study has been approved by the Riverside REC (Ref: 10/H0706/10) and has Section 251 NIGB permission under HPA reference (PIAG 03-(c)/2001).

Further Information    

Associated Publications, Resources and Links

  • Stakeholder organisations
    The following organisations have registered as project stakeholders or are partners in the National Epilepsy Audit: ...
  • Chairman's Welcome
    Dear Colleagues, Welcome. As chair of the Academic Board, I have the privilege and ...
  • Fellowships and prizes
    The College offers the following Fellowships and Awards  Fellowships for people overseas who want to ...
  • Information for investigators
    The BPSU welcomes applications from clinicians and researchers who wish to carry out national surveillance on rare ...
  • BPSU studies
    The BPSU supports studies that address a rare childhood disorder (or rare complication of a commoner disease) of such ...
  • Past studies
    Conditions for which surveillance has now completed: A Acute flacid paralysis  (1991 - 1994) ...